In a surprising revelation, a blood sample from convicted sex offender Jeffrey Epstein triggered a significant controversy within the Harvard Medical School lab of prominent geneticist George Church. The incident, which occurred in the summer of 2013, has resurfaced following new evidence about Epstein’s connections to Church and his research initiatives.
Inside Church’s lab, a refrigerator is designated for storing human biological samples, including blood and saliva from participants in the Personal Genome Project (PGP). These samples are typically held for extended periods, awaiting funding for DNA sequencing. However, when a member of the research team, Mad Ball, discovered that Epstein’s sample was being prioritized for sequencing just weeks after it arrived, alarm bells rang.
Ball’s immediate response was to investigate the identity behind the sample’s ID number. Upon discovering Epstein’s name, they were taken aback by the extensive allegations against him, including numerous accusations of sexual assault. In particular, the decision by prosecutors in Florida to downgrade serious charges against Epstein to a single solicitation charge raised ethical concerns.
“I was in such shock, I didn’t even have words,” Ball recounted in an interview. “It looked like a quid pro quo sort of thing, which would have been upsetting but not super upsetting if it wasn’t a bad person but just a rich person. But this was a rich, bad person, and it looked awful.”
The emotional turmoil among staff led to a rapid response to halt any special treatment for Epstein’s sample. Internal emails and interviews with lab personnel reveal that Church’s team collectively voiced their objections, ensuring that the sequencing of Epstein’s blood did not proceed as initially planned.
Epstein’s connections to Church date back over two decades, and while some of these relationships have been publicly documented, the extent of the backlash within the PGP has not been widely reported until now. Recent disclosures from the Department of Justice indicate that Church received funding from Epstein or his associates shortly after the incident. This revelation adds a layer of complexity to the ongoing narrative surrounding Epstein’s influence in various sectors, including academia.
The implications of this incident are far-reaching, calling into question not only the ethical considerations in research but also the integrity of funding sources in scientific endeavors. As the effects of Epstein’s actions continue to reverberate through various institutions, the incident at Harvard serves as a stark reminder of the intersections between wealth, power, and ethics in scientific research.
The full impact of this controversy on Church’s work and the broader scientific community remains to be seen, but it certainly raises important questions about accountability and transparency in academia.
